Helping patients with gastroesophageal cancer avoid unnecessary chemotherapy

A Peter Mac-led international clinical trial has found a way to personalize treatment for gastroesophageal cancer, identifying patients who could avoid further intensive rounds of chemotherapy while they recover from surgery. Each year more than 1,700 Australians are diagnosed with gastroesophageal cancer, which has a five-year survival rate of less than 25%.

The UNTHINKABLE Happens When Woman Visits Her Husband In Jail... #shorts
- National Security Council adds Gmail to its list of bad decisions - Anna Washenko
- Texas measles outbreak spills into third state as cases reach 258 - Beth Mole
- 70s Sci-Fi Hit From Legendary Author Is Forgotten Today, But Everyone Knows The Remake - Jonathan Klotz
- 7 Best Mobile Home Loans of April 2025
- YRKKH Written Update 11 August 2024: Abhira Refuses to Marry Arman as Ruhi’s Plan Unfolds! - Aaradhana Chaurasia
- Sam Altman says that OpenAI’s capacity issues will cause product delays - Kyle Wiggers

Is This the Macbook Killer? Ft. Galaxy Book 5 360!
- HYBE IM raises $21M to boost publishing and IP-based games - Dean Takahashi
- Blood cancer patients on Bruton's tyrosine kinase inhibitors should continue at time of COVID-19 vaccination, study says
- ChatGPT isn’t the only chatbot that’s gaining users - Kyle Wiggers
- The life story behind Tetris, The Perfect Game | Henk Rogers interview - Dean Takahashi
- After I Got Diagnosed With Diabetes, My Relationships Changed—Here's How - Alysse Dalessandro
- The 4 Main Types of Stomach Cancer - Carrie Madormo, RN, MPH